Eversept Partners, LP Bristol Myers Squibb CO Transaction History

Eversept Partners, LP

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 14, 2022	SELL	$53.63 - $62.52 $24.9 Million - $29.1 Million	-464,801 Closed	0 $0
Q3 2021 Nov 08, 2023	SELL	$59.17 - $69.31 $800,392 - $937,556	-13,527 Reduced 2.83%	464,801 $27.5 Million
Q3 2021 Nov 15, 2021	SELL	$59.17 - $69.31 $800,392 - $937,556	-13,527 Reduced 2.83%	464,801 $27.8 Million
Q2 2021 Nov 08, 2023	BUY	$61.91 - $67.42 $29.6 Million - $32.2 Million	478,328 New	478,328 $32 Million
Q2 2021 Aug 16, 2021	BUY	$61.91 - $67.42 $29.6 Million - $32.2 Million	478,328 New	478,328 $32 Million

2,536

1.47B

31.6M

35M

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $123B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

Get notified when there are updates to the investment portfolio of Eversept Partners, LP, based on Form 13F filings with the SEC.

Stay updated on Eversept Partners, LP with notifications on news.